Log In
Print this Print this

Arzerra, ofatumumab (HuMax-CD20)

Also known as: 2F2

  Manage Alerts
Collapse Summary General Information
Company Genmab A/S
DescriptionHuman mAb against CD20
Molecular Target CD20
Mechanism of ActionBinds CD20; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today